Back to trial details

Intake questionnaire

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Applying to The University of Chicago Medical Center ( Site 0118) · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Carcinoma, Non-Small-Cell Lung?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Chicago for study visits?